Wei Yao

735 total citations
44 papers, 566 citations indexed

About

Wei Yao is a scholar working on Molecular Biology, Surgery and Pharmacology. According to data from OpenAlex, Wei Yao has authored 44 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Wei Yao's work include Natural product bioactivities and synthesis (6 papers), Phosphodiesterase function and regulation (4 papers) and Neuropeptides and Animal Physiology (3 papers). Wei Yao is often cited by papers focused on Natural product bioactivities and synthesis (6 papers), Phosphodiesterase function and regulation (4 papers) and Neuropeptides and Animal Physiology (3 papers). Wei Yao collaborates with scholars based in China, United States and Japan. Wei Yao's co-authors include Chang‐Xin Zhou, Lawrence P. Wennogle, Robert E. Davis, Joseph P. Hendrick, Li‐She Gan, Gretchen L. Snyder, Hongwen Zhu, Jian‐Xia Mo, Kimberly E. Vanover and Sharon Mates and has published in prestigious journals such as Circulation, Scientific Reports and Biological Psychiatry.

In The Last Decade

Wei Yao

38 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Yao China 15 292 126 75 61 59 44 566
Murli Mishra United States 11 328 1.1× 50 0.4× 33 0.4× 49 0.8× 23 0.4× 18 618
Azza A. Ali Egypt 16 165 0.6× 59 0.5× 47 0.6× 34 0.6× 30 0.5× 59 589
Shinichi Uchida Japan 13 228 0.8× 54 0.4× 36 0.5× 47 0.8× 71 1.2× 23 623
Szczepan Mogilski Poland 16 338 1.2× 116 0.9× 187 2.5× 44 0.7× 168 2.8× 48 700
Carlos Fernandes‐Lopes Portugal 11 217 0.7× 75 0.6× 25 0.3× 43 0.7× 41 0.7× 24 754
Qing Tong China 18 368 1.3× 67 0.5× 22 0.3× 31 0.5× 95 1.6× 43 970
S. Sırrı Bilge Türkiye 11 143 0.5× 95 0.8× 60 0.8× 12 0.2× 86 1.5× 28 485
Wilhelmina I. Davis United States 11 358 1.2× 271 2.2× 47 0.6× 22 0.4× 58 1.0× 12 843
Jianxin Li China 15 506 1.7× 99 0.8× 46 0.6× 19 0.3× 40 0.7× 40 767
Jingjing Wu China 15 285 1.0× 54 0.4× 23 0.3× 20 0.3× 52 0.9× 30 701

Countries citing papers authored by Wei Yao

Since Specialization
Citations

This map shows the geographic impact of Wei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yao more than expected).

Fields of papers citing papers by Wei Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yao. The network helps show where Wei Yao may publish in the future.

Co-authorship network of co-authors of Wei Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Yao. A scholar is included among the top collaborators of Wei Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Yao. Wei Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chu, Tongpeng, Xiaopeng Si, Xicheng Song, et al.. (2025). Understanding structural-functional connectivity coupling in patients with major depressive disorder: A white matter perspective. Journal of Affective Disorders. 373. 219–226. 1 indexed citations
3.
4.
Yao, Wei, et al.. (2024). Empirical Mode Decomposition for Deep Learning-Based Epileptic Seizure Detection in Few-Shot Scenario. IEEE Access. 12. 86583–86595. 8 indexed citations
5.
Snyder, Gretchen L., Peng Li, Lei Zhang, et al.. (2024). Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders. Psychopharmacology. 241(7). 1477–1490. 1 indexed citations
6.
Cheng, Yingying, et al.. (2024). Progress in the application of ultrasound in glioma surgery. Frontiers in Medicine. 11. 1388728–1388728. 4 indexed citations
7.
8.
Bai, Yaowei, Jia‐Cheng Liu, Wei Yao, et al.. (2024). Comparison of specialized stent versus generic stent and bare stent combination for transjugular intrahepatic portosystemic shunt creation. Scientific Reports. 14(1). 14439–14439. 2 indexed citations
9.
10.
Yao, Wei, et al.. (2024). Channel swapping of EEG signals for deep learning‐based seizure detection. Electronics Letters. 60(14).
11.
Wang, Song, Wei Yao, Xudong Zhu, et al.. (2022). Exploring the mechanism of the antithrombotic effects of Pueraria lobata and Pueraria lobata var. thomsonii based on network pharmacology. Journal of Ethnopharmacology. 300. 115701–115701. 17 indexed citations
12.
Rubio‐Beltrán, Eloísa, Sophie Dutheil, Wei Yao, et al.. (2021). Selective Phosphodiesterase 1 Inhibition Ameliorates Vascular Function, Reduces Inflammatory Response, and Lowers Blood Pressure in Aging Animals. Journal of Pharmacology and Experimental Therapeutics. 378(2). 173–183. 12 indexed citations
13.
Snyder, Gretchen L., Jos Prickaerts, Lei Zhang, et al.. (2016). Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats. Psychopharmacology. 233(17). 3113–3124. 49 indexed citations
14.
Li, Peng, Hailin Zheng, Jun Zhao, et al.. (2016). Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases. Journal of Medicinal Chemistry. 59(3). 1149–1164. 64 indexed citations
15.
Zhou, Guangwen, Wei Yao, Xi Chen, et al.. (2010). Multiple Endocrine Neoplasia Type 1 Simultaneous With Various Types of Enteropancreatic Endocrine Tumors. Pancreas. 39(5). 680–683. 1 indexed citations
16.
Peng, Youyi, Qiang Zhang, Gretchen L. Snyder, et al.. (2010). Discovery of novel α7 nicotinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(16). 4825–4830. 19 indexed citations
17.
Zheng, Qunxiong, Zhaojun Xu, Wei Yao, et al.. (2003). Eudesmane and megastigmane glucosides from Laggera alata. Phytochemistry. 63(7). 835–839. 29 indexed citations
18.
Zhang, Yongdong, et al.. (2002). Topical application of halcinonide cream reduces the severity and incidence of intraperitoneal adhesions in a rat model. The American Journal of Surgery. 184(1). 74–77. 14 indexed citations
19.
Zhang, Yaohui, Ruigang Li, Sung‐Kwon Hong, et al.. (2002). Nano-scale Recessed Asymmetric Schottky Contacted CMOS. 195–200. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murli Mishra Breakdown of academic impact, for papers by Azza A. Ali Breakdown of academic impact, for papers by Shinichi Uchida Breakdown of academic impact, for papers by Szczepan Mogilski Breakdown of academic impact, for papers by Carlos Fernandes‐Lopes Breakdown of academic impact, for papers by Qing Tong Breakdown of academic impact, for papers by S. Sırrı Bilge Breakdown of academic impact, for papers by Wilhelmina I. Davis Breakdown of academic impact, for papers by Jianxin Li Breakdown of academic impact, for papers by Jingjing Wu
Rankless by CCL
2026